Latest News


Boehringer Ingelheim speaker event

What Can We Learn About the Evolving Squamous NSCLC Treatment Landscape


Updated Patient Assistance Program

Janssen Carepath Patient Support Program


NOVARTIS drug ADAKVEO receives new J-code effective 7/1/2020

Novartis is pleased to announce that for dates of service on or after July 1, 2020, the Centers for Medicare and Medicaid Services (CMS) has issued a product-specific J-code: J0791 for injection, crizanlizumab-tmca, 5 mg. The updated billing unit is 5 mg.


NPPES and the NPI Registry

Many of you have noted the recent instability of NPPES and the NPI Registry. CMS has begun implementing changes that should eliminate the instability. We expect that these changes will be completed next week.

News & Events